Organization | Centre de Recherche en Sante de Nouna, Burkina Faso

Centre de Recherche en Sante de Nouna, Burkina Faso Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4

Founded: Nouna Department Burkina Faso (1992)

Organization Overview

First Clinical Trial

2005

NCT00261222

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2024

Timeline

NOW

Now

Alternative names

Centre de Recherce en Sante de Nouna | Centre de Recherche en Sante de Nouna, Burkina Faso

Active Ingredients

Drugs in Phase 4 Trials (4)

amoxicillin (2 trials)

attenuated measles vaccine - Edmonston strain (rubeovax) (2 trials)

azithromycin (zithromax) (8 trials)

sulfamethoxazole (gantanol) (1 trial)

Drugs in Phase 3 Trials (2)

folic acid (1 trial)

Drugs in Phase 2 Trials (3)

amodiaquine (camoquin) (1 trial)

methylene blue (proveblue) (1 trial)

primaquine (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Malaria (Phase 4)

Malaria, Falciparum (Phase 2)

Measles (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 13
# of Trial APIs: 9